Sentinel lymph node biopsy after neoadjuvant systemic therapy. Surg Clin North Am. 2003;83:931-942. Abstract. Julian TB, Dusi D, Wolmark N. Sentinel node biopsy after neoadjuvant chemotherapy for ...

Routine SLNB may be used to predict tumor invasion levels and SLN metastasis in patients with EMPD who do not have enlarged lymph nodes.

Undergoing sentinel lymph node biopsy and radical hysterectomy without pelvic lymphadenectomy may reduce the risk of retroperitoneal nodal recurrence and cancer-specific death.

Background: Axillary management after sentinel lymph node biopsy (SLNB) is still debated for clinically node-positive breast cancer (BC) patients treated with neoadjuvant chemotherapy (NAC). The ...

To update the ASCO evidence-based recommendations on the use of sentinel lymph node biopsy (SLNB) in patients with early-stage breast cancer treated with initial surgery. Methods ASCO convened an ...

By Karen Roman Oncology-focused biotech company SkylineDx said an independent study shows that Merlin CP-GEP, the company’s test for treatment decisions in early-stage melanoma, correctly categorizes ...

The lymph node stroma model offers a platform to test complex fluid flow and retention of T cells, which support the immune system and fight disease.. The research also points to the importance of ...

Lymph node transfer is often performed at the same time as the breast operated on for cancer is reconstructed with a tissue flap taken from the patient's abdomen.

Omitting Sentinel-Node Biopsy in Small Breast Cancers. 2025-03-13. DOI: 10.1056/NEJMdo007895 Save. Permissions ...